Intrinsiqq
Guardian Pharmacy Services Inc. logo

Guardian Pharmacy Services Inc. (GRDN) Insider Trading

Last 12 months

Insiders bought $100k and sold $280M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Thomas J Salentine Jr sold $106M on Mar 20, 44% of their stake, outside a plan.

Net open-market
−$280M
1 buy · 6 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 6
executives and directors
Last open-market buy
Dec 2025
Dec 3, 2025

Get an email when GRDN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 20No plan
    David K Morris
    See Remarks · sold 187,855 at $29.68
    $5.58M
    42% of stake
  • Mar 20No plan
    Pharmacy Investors, LLC
    Large holder · sold 827,636 at $29.68
    $24.6M
    44% of stake
  • Mar 20No plan
    Fred Burke
    See Remarks · sold 671,432 at $29.68
    $19.9M
    44% of stake
  • Mar 20No plan
    Thomas J Salentine Jr
    Director · sold 3,570,677 at $29.68
    $106M
    44% of stake
  • Mar 20No plan
    Bindley Capital Partners I, LLC
    Large holder · sold 3,570,677 at $29.68
    $106M
    44% of stake
  • Mar 20No plan
    John Ackerman
    Director · sold 1,103,364 at avg $29.68
    $32.7M
    44% of stake
  • Mar 20No plan
    William E Bindley
    Director · sold 3,570,677 at $29.68
    $106M
    44% of stake
  • Mar 20No plan
    Kendall Forbes
    See Remarks · sold 346,672 at $29.68
    $10.3M
    43% of stake
  • Mar 20No plan
    Cardinal Equity Fund, L.p.
    Large holder · sold 275,728 at $29.68
    $8.18M
    44% of stake
  • Dec 3, 2025
    Steven D Cosler
    Director · bought 3,370 at $29.61
    $100k
    16% of stake
  • May 27, 2025 – May 28, 2025No plan
    Cardinal Equity Fund, L.p.
    Large holder · sold 321,263 at avg $20.16
    $6.48M
    34% of stake
  • May 27, 2025 – May 28, 2025No plan
    Pharmacy Investors, LLC
    Large holder · sold 964,316 at avg $20.16
    $19.4M
    34% of stake
  • May 27, 2025 – May 28, 2025No plan
    William E Bindley
    Director · sold 4,160,359 at avg $20.16
    $83.9M
    68% of stake
  • May 27, 2025 – May 28, 2025No plan
    Thomas J Salentine Jr
    Director · sold 4,160,359 at avg $20.16
    $83.9M
    68% of stake
  • May 27, 2025 – May 28, 2025No plan
    John Ackerman
    Director · sold 1,285,579 at avg $20.16
    $25.9M
    68% of stake
  • May 27, 2025 – May 28, 2025No plan
    David K Morris
    See Remarks · sold 437,759 at avg $20.16
    $8.83M
    67% of stake
  • May 27, 2025 – May 28, 2025No plan
    Fred Burke
    See Remarks · sold 885,807 at avg $20.16
    $17.9M
    68% of stake
  • May 27, 2025 – May 28, 2025No plan
    Kendall Forbes
    See Remarks · sold 415,049 at avg $20.16
    $8.37M
    67% of stake
  • May 27, 2025 – May 28, 2025No plan
    Bindley Capital Partners I, LLC
    Large holder · sold 4,160,359 at avg $20.16
    $83.9M
    68% of stake
  • Nov 19, 2024
    Steven D Cosler
    Director · bought 7,000 at $21.22
    $149k
    65% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GRDN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Retail-Drug Stores and Proprietary Stores

Spot a number that looks wrong? Check it in GRDN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GRDN

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.